Our CEO, Sho Okiyama, participated in G1 Global Conference 2020 "Disruptive Evolution Post-COVID-19 : Geopolitics, Business and Society" as a panelist.

Our CEO, Sho Okiyama, participated in Healthcare Venture Knot 2020.

Aillis participated in NVIDIA GPU TECHNOLOGY CONFERENCE (GTC) AI Startup Pavilion.

Our CSO, Hiroaki Kato, was interviewed by Japanese Magazine PRESIDENT.

Our CSO, Hiroaki Kato, gave a presentation at Yokohama City University's seminar.

Our CSO, Hiroaki Kato, gave a presentation at SDGs Mirai Kaigi 2020 Business Conference.

Our CEO, Sho Okiyama, gave a lecture at Waseda Business School.

Our CEO, Sho Okiyama, participated in the 60th annual meeting of The Japanese Respiratory Society.

Our CSO, Hiroaki Kato, gave a presentation at Komatsu University Public Forum.

Our CSO, Hiroaki Kato, was interviewed by Vision and Strategy, August 20.

Our COO, Tanaka, and our business manager, Akane, Launched the IoMD working group at the Japan Digital Therapeutics Association.

Our CEO, Sho Okiyama, participated in 21st Century Advanced Medical Consortium

Our COO Tanaka has been appointed as a health care expert.

Our COO Tanaka participated in AI medical device development seminar

Our COO, Tanaka, was interviewed by Medical DX.

Aillis funded by Mirai Creation Fund (backed by Toyota) and Cyberdyne.

Hiroshi Yoshihara won a gold medal in PANDA Challenge on Kaggle and became a Kaggle Master.

Our CSO, Hiroaki Kato, participated in an online event by Antaa.

Our CSO, Hiroaki Kato, was interviewed by Medical DX.

Our COO, Daichi Tanaka, contributed an article to Technical Information Institute: "Thinking Healthcare Business in the With-Corona Era".